Prediagnostic C-peptide and risk of prostate cancer.
Borugian
Marilyn J
MJ
Cancer Control Research, British Columbia Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia, Canada V5Z 1L3. mborugian@bccrc.ca
Spinelli
John J
JJ
Sun
Zheng
Z
Kolonel
Laurence N
LN
Oakley-Girvan
Ingrid
I
Pollak
Michael D
MD
Whittemore
Alice S
AS
Wu
Anna H
AH
Gallagher
Richard P
RP
D014408:Biomarkers, Tumor / Q000097:blood*; D002096:C-Peptide / Q000097:blood*; D016022:Case-Control Studies; D003687:Dehydroepiandrosterone / Q000097:blood; D042241:Early Diagnosis; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000097:blood / Q000175:diagnosis*; D012044:Regression Analysis; D012307:Risk Factors; D013223:Statistics as Topic; D013739:Testosterone / Q000097:blood
D014408:Biomarkers, Tumor; D002096:C-Peptide; D013739:Testosterone; D003687:Dehydroepiandrosterone